Open Access<p>Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma</p>
Author(s) -
Genping Huang,
Ruizhe Chen,
Nanjia Lu,
Qin Chen,
Weiguo Lü,
Baohua Li
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s250614
Subject(s) - medicine , carcinoembryonic antigen , stage (stratigraphy) , receiver operating characteristic , biomarker , oncology , gastroenterology , cervical cancer , adenocarcinoma , proportional hazards model , oncofetal antigen , cancer antigen , cancer , immunotherapy , paleontology , biochemistry , chemistry , tumor associated antigen , biology
There is currently a lack of research on preoperative prognostic analysis of early-stage cervical adenocarcinoma (ADC). The purpose of our study was to clarify whether preoperative serum tumor-marker levels were of prognostic value in early-stage ADC.